英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
undramatically查看 undramatically 在百度字典中的解释百度英翻中〔查看〕
undramatically查看 undramatically 在Google字典中的解释Google英翻中〔查看〕
undramatically查看 undramatically 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Multiple Myeloma Treatments | Drugs Treatment by Stage - MMRF
    You and your doctor will determine a treatment plan designed for you and the specifics of your multiple myeloma diagnosis Treatment options for triple-class refractory multiple myeloma have seen great advances in the last few years Ninlaro is an oral drug that is given in combination with another drug if you have previously received
  • NINLARO® For Relapsed Multiple Myeloma - Patient Information
    NINLARO is the first and only oral medication of its kind, a proteasome inhibitor, that may help people when their multiple myeloma comes back In a study of multiple myeloma patients whose disease had returned after a prior treatment, the combination of NINLARO plus REVLIMID ® (lenalidomide) and dexamethasone was shown to improve the time people were able to live with their multiple myeloma
  • Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the . . .
    Multiple myeloma is a cancer of plasma cells in the bone marrow that often leads to bone destruction and bone marrow failure 1,2 According to the American Cancer Society, more than 26,800 new cases of multiple myeloma were diagnosed in 2015, and 11,240 deaths were attributed to the disease 3 Representing approximately 1% of all cancers, multiple myeloma is the second most common hematologic
  • NINLARO® (ixazomib) Treatment Guide
    one prior treatment for their multiple myeloma NINLARO should not be used to treat the following people, unless they are participants in a controlled clinical trial: • people who are receiving maintenance treatment, or • people who have been newly diagnosed with multiple myeloma It is not known if NINLARO is safe and effective in children
  • Myeloma Patients Refractory to Revlimid May Benefit from Ninlaro . . .
    In a prior Phase 3 trial (NCT01564537), adding Ninlaro to a regimen with Revlimid and the corticosteroid dexamethasone improved patients’ progression-free survival, the length of time without the disease worsening after starting a new treatment These results led to the approval of this triple combo for the treatment of relapsed multiple myeloma
  • Ixazomib (Ninlaro®) Treatment Guide - Myeloma UK
    Ixazomib (Ninlaro ®) Treatment Guide This Treatment Guide contains information about ixazomib, a drug used in the treatment of myeloma This publication is part of our Treatment Guide series, a collection of publications covering different drugs used in the treatment of myeloma They are designed to be mixed-and-matched to correspond to your
  • Relapsed Refractory Multiple Myeloma: How Treatment Changes - WebMD
    To create the best treatment plan for relapsed refractory multiple myeloma (RRMM), health care providers look at the big picture They carefully think about several important things
  • Relapsed and Refractory Multiple Myeloma - StatPearls - NCBI Bookshelf
    Multiple myeloma (MM) is a malignant disorder of B cells that involves the proliferation of abnormal monoclonal plasma cells in the bone marrow and or extramedullary sites; it is the second most common hematological malignancy associated with significant morbidity and mortality by causing end-organ damage Over the last few decades, MM survival rates have been prolonged due to recent
  • Ninlaro (ixazomib) - International Myeloma Foundation
    Ninlaro® (ixazomib) is an oral prescription medicine used to treat multiple myeloma in combination with the medicines Revlimid® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment It belongs to a class of drugs known as proteasome inhibitors
  • MULTIPLE MYELOMA RELAPSE GUIDE - NINLARO® (ixazomib)
    Increasing M protein levels are a sign of multiple myeloma relapse Multiple myeloma cells make an abnormal antibody called M protein M protein can accumulate in the blood or urine of people with multiple myeloma and increasing levels can be an early sign of a relapse Your journey with multiple myeloma is unique and so are your M protein levels





中文字典-英文字典  2005-2009